Corey Goodman is a scientist, educator, and entrepreneur. Dr. Goodman spent 25 years as Professor of Biology at Stanford University and then Evan Rauch Chair of Neurobiology at Berkeley, where he was Howard Hughes Medical Institute Investigator, Head of the Neurobiology Division, and co-founder and Director of the Wills Neuroscience Institute. Since moving into the private sector, he is currently Adjunct Professor of Neuroscience in the Wills Neuroscience Institute at U.C. Berkeley.
Dr. Goodman received his B.S. degree from Stanford University, his Ph.D. from University of California Berkeley, and trained as a Helen Hay Whitney postdoctoral fellow at U.C. San Diego.
Dr. Goodman is an elected member of the National Academy of Sciences, American Academy of Arts and Sciences, and American Philosophical Society, and recipient of many honors including the Alan T. Waterman Award, Canada Gairdner Biomedical Award, March-of-Dimes Prize in Developmental Biology, Reeve-Irvine Research Medal, and Dawson Prize in Genetics from Trinity College Dublin.
Dr. Goodman has co-founded seven biotechnology companies and led one of them as CEO from a private to public company until its acquisition. He was recruited to be President and founder of Pfizer’s Biotherapeutics and Bioinnovation Center and a member of Pfizer’s executive leadership team.
Today Dr. Goodman is a Managing Partner of venBio Partners LLC, a venture capital firm he co-founded that focuses on innovative therapeutics for major unmet medical needs. Dr. Goodman is Chair of the board of five companies, and a member of the board of another. He chaired another company (Labrys) until its acquisition by Teva.
Amongst his many public policy roles, Dr. Goodman is Chair of the California Council on Science and Technology (advising the Governor and State Legislature of California), a member of the University of California Innovation Council, a member of the board of the Pacific Institute, former Chair of the National Research Council's Board on Life Sciences (advising the Federal Government), and past President of the McKnight Endowment Fund for Neuroscience.